Naloxone Dispensing Rate Maps

For Everyone

Key points

  • More than 1.9 million naloxone prescriptions were dispensed from retail pharmacies in 2024.
  • The overall rate of naloxone dispensed from retail pharmacies in the US increased from 0.3 per 100 persons in 2019 to 0.6 in 2023 and remained at 0.6 in 2024.
  • Naloxone dispensing rates varied widely across the country.
  • States with the highest naloxone dispensing rates per 100 persons in 2024 include: Arkansas (1.7), New Mexico (1.4), Kentucky (1.2), District of Columbia (1.2), and Rhode Island (1.1).
  • States with the lowest naloxone dispensing rates per 100 persons in 2024 include: Minnesota (0.2) and South Dakota (0.2).

Naloxone data

Naloxone and other opioid overdose reversal agents are life-saving medications.12 The data in the maps show the geographic distribution in the United States of retail pharmacy dispensed naloxone prescriptions per 100 persons per year from 2019–2024.A

Data are displayed as maps that portray the estimated rate of naloxone prescriptions per 100 persons per year for each of the 50 states and the District of Columbia.B Click on a state to reveal its naloxone dispensing rate or view the corresponding data table for additional information.

State naloxone dispensing rates

Note: Data are subject to change with future updates.

Content Source
National Center for Injury Prevention and Control
About This Page
Published: May 15, 2024
Updated: August 11, 2026

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: August 11, 2026

The information on this page was last reviewed by subject matter experts to ensure accuracy.

  1. Source for all dispensing data: IQVIA Xponent 2019–2024. IQVIA Xponent is based on a sample of approximately 54,600 retail (non-hospital) pharmacies, which dispense nearly 94% of all retail prescriptions in the United States. For this database, a prescription is a new or refilled prescription dispensed at a retail pharmacy in the sample and paid for by commercial insurance, Medicaid, Medicare, cash or its equivalent, and other third-party coverage. This database does not include mail-order prescriptions. Geographic location is based on the location of the prescriber. Methadone dispensed through methadone treatment programs is not included in the IQVIA Xponent data. For the calculation of dispensing rates, numerators are the projected total number of naloxone prescriptions dispensed annually at the state, county, or national level. Annual resident population denominators were obtained from the U.S. Census Bureau.
  2. These data do not include naloxone sold over the counter.